Isabel Kurth

Company: Inspirna, Inc.

Job title: Senior Vice President, Research

Seminars:

Inhibiting Phosphocreatine Dependent Energetic Pathway in RAS-Driven Colorectal Cancer by Blocking the SLC6A8 Creatine Transporter by Ompenaclib 3:45 pm

• CKB overexpression pathway in RAS mutated mCRC as a therapeutic target • Ompenaclib – an oral small molecule blocking SLC 6A8 transport of phosphocreatine • Pre-clinical and clinical data of ompenaclib activity in RAS mutated mCRCRead more

day: Day Two